{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:23:37Z","timestamp":1790796217998,"version":"4.1.0"},"reference-count":9,"publisher":"Japanese Society of Internal Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,4,1]]},"DOI":"10.2169\/internalmedicine.3928-19","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T22:04:18Z","timestamp":1575583458000},"page":"977-981","source":"Crossref","is-referenced-by-count":20,"title":["Renal Effects after Pembrolizumab Treatment for Non-small Cell Lung Carcinoma"],"prefix":"10.2169","volume":"59","author":[{"given":"Rikako","family":"Oki","sequence":"first","affiliation":[{"name":"Division of Nephrology and Endocrinology, The University of Tokyo Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Hirakawa","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Endocrinology, The University of Tokyo Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Endocrinology, The University of Tokyo Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenjiro","family":"Honda","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Endocrinology, The University of Tokyo Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munetoshi","family":"Hinata","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Tokyo Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Tokyo Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukako","family":"Domoto","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Tokyo Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goh","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahide","family":"Nagase","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaomi","family":"Nangaku","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Endocrinology, The University of Tokyo Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Antonia SJ, Villegas A, Daniel D, et al. Durvalumab after chemoradiotherapy in stage III non-small-cell lung Cancer. N Engl J Med 377: 1919-1929, 2017.","DOI":"10.1056\/NEJMoa1709937"},{"key":"2","unstructured":"2. Mamlouk O, Selamet U, Machado S, et al. Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience. J Immuno ther Cancer 7: 2, 2019."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kishi S, Minato M, Saijo A, et al. IgA nephropathy after nivolumab therapy for postoperative recurrence of lung squamous cell carcinoma. Intern Med 57: 1259-1263, 2018.","DOI":"10.2169\/internalmedicine.9814-17"},{"key":"4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1074-7613(00)80089-8","volume":"11","author":"H Nishimura","year":"1999","unstructured":"4. Nishimura H, Nose M, Hiai H, et al. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11: 141-151, 1999.","journal-title":"Immunity","ISSN":"https:\/\/id.crossref.org\/issn\/1074-7613","issn-type":"print"},{"key":"5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4161\/gmic.23595","volume":"4","author":"M Maruya","year":"2013","unstructured":"5. Maruya M, Kawamoto S, Kato L, et al. Impaired selection of IgA and intestinal dysbiosis associated with PD-1-deficiency. Gut Microbes 4: 165-171, 2013.","journal-title":"Gut Microbes","ISSN":"https:\/\/id.crossref.org\/issn\/1949-0976","issn-type":"print"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Angelis M, Montemurno E, Piccolo M, et al. Microbiota and metabolome associated with immunoglobulin A nephropathy (IgAN). PLoS One 9: e99006, 2014.","DOI":"10.1371\/journal.pone.0099006"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Moledina D, Perazella M. Treatment of drug-induced acute tubulointerstitial nephritis. Clin J Am Soc Nephrol 13: 1785-1787, 2018.","DOI":"10.2215\/CJN.12001018"},{"key":"8","unstructured":"8. Dumenil C, Massiani M, Dumoulin J, et al. Clinical factors associated with early progression and grade 3-4 toxicity in patients with advanced non-small-cell lung cancers treated with nivolumab. PLoS One. Forthcoming."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Robert C, Ribas A, Hamid O, et al. Durable complete response after discontinuation of pembrolizumab in patients with metastatic melanoma. J Clin Oncol 36: 1668-1674, 2018.","DOI":"10.1200\/JCO.2017.75.6270"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/7\/59_3928-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T20:30:45Z","timestamp":1665174645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/7\/59_3928-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":9,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3928-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,1]]}}}